BELLOCCHI, MARIA CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 10.719
EU - Europa 992
AS - Asia 171
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
OC - Oceania 1
Totale 11.899
Nazione #
US - Stati Uniti d'America 10.713
IT - Italia 261
IE - Irlanda 123
UA - Ucraina 121
SE - Svezia 117
DE - Germania 111
CN - Cina 103
PL - Polonia 69
FR - Francia 68
GB - Regno Unito 47
KR - Corea 37
FI - Finlandia 34
BE - Belgio 19
RU - Federazione Russa 16
CA - Canada 6
HK - Hong Kong 6
IN - India 5
JP - Giappone 5
VN - Vietnam 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
CH - Svizzera 3
CL - Cile 3
SG - Singapore 3
EU - Europa 2
MN - Mongolia 2
PE - Perù 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
GH - Ghana 1
IQ - Iraq 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NL - Olanda 1
ZW - Zimbabwe 1
Totale 11.899
Città #
Woodbridge 2.981
Wilmington 2.827
Houston 2.533
Fairfield 419
Chandler 299
Ann Arbor 242
Ashburn 185
Seattle 179
Rome 148
Cambridge 137
Dublin 109
Jacksonville 103
Medford 84
Creede 77
New York 74
Kraków 69
Dearborn 53
Beijing 50
Lawrence 38
San Diego 26
Milan 24
Santa Clara 23
Colorado Springs 22
Mülheim 20
Brussels 19
Zhengzhou 15
Menlo Park 13
Mountain View 12
London 9
Redwood City 9
Falls Church 8
Guangzhou 8
Boardman 7
Florence 7
Helsinki 7
Magenta 7
Seoul 7
Hong Kong 6
Norwalk 6
Cedarhurst 5
Dong Ket 5
Kunming 5
Palo Alto 5
University Park 5
Binasco 4
Cagliari 4
Hefei 4
Los Angeles 4
Monte Vista 4
Phoenix 4
Saint Petersburg 4
San Mateo 4
Vasto 4
Verona 4
Chiswick 3
Detroit 3
Fuzhou 3
Hounslow 3
La Veta 3
North Hollywood 3
Padova 3
Pune 3
Toronto 3
Wuhan 3
Acton 2
Albano Laziale 2
Bagnoregio 2
Bologna 2
Engelhard 2
Jinan 2
Kyiv 2
Lima 2
Montréal 2
Nanchang 2
Nanjing 2
Nepi 2
Paris 2
Sacramento 2
San Francisco 2
Shanghai 2
Shaoxing 2
São Paulo 2
Tokyo 2
Zurich 2
Adliswil 1
Almaty 1
Andover 1
Arcore 1
Auburn Hills 1
Augusta 1
Bobrynets 1
Canberra 1
Cassino 1
Changsha 1
Chengdu 1
Chieti 1
Colombo 1
Costa Mesa 1
Council Bluffs 1
El Talar 1
Totale 11.013
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 489
Virologic correlates of adherence to antiretroviral medications and therapeutic failure 454
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 452
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 437
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 426
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso 426
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 419
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 414
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors 413
Population variation analysis at nine loci containing expressed trinucleotide repeats 412
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 411
Population variation analysis at nine loci containing expressed trinucleotide repeats 409
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 397
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 396
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy 396
Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage 376
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 375
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme 373
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B 371
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy 366
Dynamics of NRTI resistance mutations during therapy interruption 364
Temporal change in the use of genotypic resistance testing over the years 1999--2003 360
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors 359
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir 348
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 339
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 326
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 323
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 231
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 170
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 155
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 146
Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation 110
Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis 91
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 54
HHV-8 genetic diversification and its impact on severe clinical presentation of associated diseases 45
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 44
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 42
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 38
Characterization of HBV and HCV minority quasispecies by Ultra-Deep Pyrosequencing analysis: impact on pathogenicity and response to antiviral drugs 36
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 29
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 28
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 24
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 23
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 20
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 16
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 16
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 14
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 13
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 12
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen 11
Long-term evaluation of the effect of genotype-based antiretroviral therapy upon virological, immunological, and clinical parameters 11
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. 11
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients 11
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort 10
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase 10
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure 10
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure 9
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy 9
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation 8
Using a database of genotype resistance tests to describe characteristics related to detection of the multinucleoside resistance-associated Q151M mutation. 8
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 6
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors 4
Totale 12.106
Categoria #
all - tutte 24.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019620 0 0 0 0 0 0 0 0 0 0 346 274
2019/20203.126 246 232 205 273 259 341 280 272 294 292 206 226
2020/20212.052 225 247 244 242 210 232 248 192 39 72 69 32
2021/2022583 39 48 33 33 21 36 28 30 126 45 26 118
2022/2023982 78 69 54 95 68 137 41 259 56 70 43 12
2023/2024294 58 9 29 17 32 94 10 11 13 21 0 0
Totale 12.106